James Mason

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

H. Kohrt, J. Berek, A. Secord, 2016, Journal of Immunotherapy for Cancer.